Tabea Kaul, Bas E Kellerhuis, Johanna Aa Damen, Ewoud Schuit, Kevin Jenniskens, Maarten van Smeden, Johannes B Reitsma, Lotty Hooft, Karel Gm Moons, Bada Yang
{"title":"Methodological Quality Assessment Tools for Diagnosis and Prognosis Research: Overview and Guidance.","authors":"Tabea Kaul, Bas E Kellerhuis, Johanna Aa Damen, Ewoud Schuit, Kevin Jenniskens, Maarten van Smeden, Johannes B Reitsma, Lotty Hooft, Karel Gm Moons, Bada Yang","doi":"10.1016/j.jclinepi.2024.111609","DOIUrl":null,"url":null,"abstract":"<p><strong>Background and objective: </strong>Multiple tools exist for assessing the methodological quality of diagnosis and prognosis research. It can be challenging to decide on when to use which tool. We aimed to provide an overview of existing methodological quality assessment (QA) tools for diagnosis and prognosis studies, highlight the overlap and differences among these tools, and to provide guidance for choosing the appropriate tool.</p><p><strong>Study design and setting: </strong>We performed a methodological review of tools designed for assessing risk of bias, applicability, or other aspects related to methodological quality in studies investigating tests/factors/markers/models for classifying or predicting a current (diagnosis) and/or future (prognosis) health state. Tools focusing exclusively on causal research or on reporting quality were excluded. Guidance was subsequently developed to assist in choosing an appropriate QA tool.</p><p><strong>Results: </strong>We identified 14 QA tools, eight of which were developed for assessment of diagnosis studies, four for prognosis studies, and two addressing both. We propose a set of five questions to help guide the process of choosing a QA tool based on the purpose or question of the user: whether the focus is on (1) diagnosis, prognosis, or another domain; (2) a prediction model versus a test/factor/marker; (3) evaluating simply the performance of a test/factor/marker versus assessing its added value over other variables; (4) comparing two or more tests/factors/markers/models; and (5) whether the user aims to assess only risk of bias or also other quality aspects.</p><p><strong>Conclusion: </strong>Existing QA tools for appraising diagnosis and prognosis studies vary in purpose, scope, and contents. Our guidance may help researchers, systematic reviewers, health policy makers, and guideline developers in specifying their purpose and question to select the most appropriate QA tool for their assessment.</p>","PeriodicalId":51079,"journal":{"name":"Journal of Clinical Epidemiology","volume":" ","pages":"111609"},"PeriodicalIF":7.3000,"publicationDate":"2024-11-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Clinical Epidemiology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.jclinepi.2024.111609","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"HEALTH CARE SCIENCES & SERVICES","Score":null,"Total":0}
引用次数: 0
Abstract
Background and objective: Multiple tools exist for assessing the methodological quality of diagnosis and prognosis research. It can be challenging to decide on when to use which tool. We aimed to provide an overview of existing methodological quality assessment (QA) tools for diagnosis and prognosis studies, highlight the overlap and differences among these tools, and to provide guidance for choosing the appropriate tool.
Study design and setting: We performed a methodological review of tools designed for assessing risk of bias, applicability, or other aspects related to methodological quality in studies investigating tests/factors/markers/models for classifying or predicting a current (diagnosis) and/or future (prognosis) health state. Tools focusing exclusively on causal research or on reporting quality were excluded. Guidance was subsequently developed to assist in choosing an appropriate QA tool.
Results: We identified 14 QA tools, eight of which were developed for assessment of diagnosis studies, four for prognosis studies, and two addressing both. We propose a set of five questions to help guide the process of choosing a QA tool based on the purpose or question of the user: whether the focus is on (1) diagnosis, prognosis, or another domain; (2) a prediction model versus a test/factor/marker; (3) evaluating simply the performance of a test/factor/marker versus assessing its added value over other variables; (4) comparing two or more tests/factors/markers/models; and (5) whether the user aims to assess only risk of bias or also other quality aspects.
Conclusion: Existing QA tools for appraising diagnosis and prognosis studies vary in purpose, scope, and contents. Our guidance may help researchers, systematic reviewers, health policy makers, and guideline developers in specifying their purpose and question to select the most appropriate QA tool for their assessment.
期刊介绍:
The Journal of Clinical Epidemiology strives to enhance the quality of clinical and patient-oriented healthcare research by advancing and applying innovative methods in conducting, presenting, synthesizing, disseminating, and translating research results into optimal clinical practice. Special emphasis is placed on training new generations of scientists and clinical practice leaders.